Showing 19,981 - 20,000 results of 100,757 for search '(( 5 step decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.12s Refine Results
  1. 19981
  2. 19982
  3. 19983
  4. 19984
  5. 19985
  6. 19986
  7. 19987
  8. 19988
  9. 19989
  10. 19990
  11. 19991
  12. 19992

    Maximum neutralization activity of bnMAbs in a TZM-bl target cell assay. by Laura E. McCoy (386535)

    Published 2015
    “…<p>(A) The bnMAbs are ordered from left to right according to decreasing medians of MPN. …”
  13. 19993

    Pre-diabetes is associated with increased risk of heart failure among patients with atrial fibrillation by Jia-Yi Huang (12733928)

    Published 2022
    “…</p> <p><strong>Results</strong>: Among 17,943 AF patients (mean age 75.5 years, 47% female), 3,711 (20.7%) had pre-diabetes and 10,127 (56.4%) had diabetes at baseline. …”
  14. 19994

    USP22 lentiviral shRNA vectors. by Xianghong Kuang (17811238)

    Published 2024
    “…<div><p>The Ubiquitin Specific Peptidase 22 (USP22), a component of the Spt-Ada-Gcn5 Acetyltransferase (SAGA) histone modifying complex, is overexpressed in multiple human cancers, but how USP22 impacts tumorigenesis is not clear. …”
  15. 19995

    Antibodies. by Xianghong Kuang (17811238)

    Published 2024
    “…<div><p>The Ubiquitin Specific Peptidase 22 (USP22), a component of the Spt-Ada-Gcn5 Acetyltransferase (SAGA) histone modifying complex, is overexpressed in multiple human cancers, but how USP22 impacts tumorigenesis is not clear. …”
  16. 19996

    qRT-PCR primers. by Xianghong Kuang (17811238)

    Published 2024
    “…<div><p>The Ubiquitin Specific Peptidase 22 (USP22), a component of the Spt-Ada-Gcn5 Acetyltransferase (SAGA) histone modifying complex, is overexpressed in multiple human cancers, but how USP22 impacts tumorigenesis is not clear. …”
  17. 19997

    Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot random... by Lívia Pimenta Bonifácio (7502579)

    Published 2023
    “…The primary outcome was accessed in the “per protocol” population as the proportion of patients with clinical improvement, defined as a decrease greater or equal to two points on the World Health Organization’s (WHO) seven-category ordinal scale by day 28. …”
  18. 19998

    FABP5 expression modulates PPAR-γ activity. by Fabienne Gally (260470)

    Published 2013
    “…<p><b>A.</b> FABP5 down regulation significantly decreases PPAR-γ activity in primary NHBE cell cultures. …”
  19. 19999
  20. 20000